.webp)

Thinning Hair in Perimenopause: The Labs a Charleston Clinic Should Run Before PRP
Hair thinning in perimenopause is common, and a Charleston clinic should check your thyroid and iron with blood work before you pay for PRP. Those causes can be found and treated [1]. PRP has real but limited evidence in women. In a meta-analysis of seven studies in women, PRP increased terminal hair density, with no significant increase in hair thickness [2].
By Ashley Harwyn, PA-C, ABAAHP | Published | Last updated

Female pattern hair loss is the most common cause of hair loss in women [3]. A European guideline says its frequency rises with age and that it affects up to 42% of women [4]. But other causes can look the same. Some of them show up on a blood test [5].
The treatment evidence is mixed in a specific way. A 2025 meta-analysis of nine randomized trials in men and women found no significant difference in hair density between PRP and topical minoxidil [6]. Low-dose oral minoxidil is another option, but it is off-label for hair [7]. In a large retrospective study, 1.7% of patients stopped it because of side effects [8].
What to bring to your hair loss visit
Builds a list of questions for your visit. It does not diagnose anything or recommend a treatment.
Thyroid blood tests in the past year
Iron studies, including ferritin, in the past year
- Ask
- Which ferritin definition are you using for my result? [10]
No recent labs, or not sure
Heavier periods lately
- Ask
- Should we check iron and hemoglobin? [17]
Tried topical minoxidil
- Ask
- How long did I use it? The women's foam label says some women need at least 6 months. [25]
Considering oral minoxidil
- Ask
- It is off-label for hair and the tablet label has a boxed warning. Is it right for my heart and blood pressure history? [7]
Considering PRP
General information from the sources in this guide, read November 2026. Your clinician decides what to test and treat. Using PRP for hair loss is off-label. [19][20]
Key takeaways
- Female pattern hair loss usually begins in a woman's 40s, 50s or 60s and is more common after menopause [3].
- Rule out thyroid disease and iron deficiency first. Nearly 5 in 100 Americans age 12 and older have hypothyroidism, and thinning hair is a listed symptom [9].
- No guideline we found sets a ferritin target for hair. Research definitions of iron deficiency vary, and the choice changes how many women are counted [10].
- The evidence table in this guide labels each PRP analysis by who was studied. The women-only analysis found more hairs, with no significant gain in thickness [2]. The two larger analyses included men [6] [11].
- Topical minoxidil is the most-recommended treatment for female pattern hair loss, says the AAD [3]. Oral minoxidil tablets carry a boxed warning and are labeled only for high blood pressure [7].
Section 01 / Why it thins
Why hair thins in perimenopause
Hair thins in perimenopause mainly because of female pattern hair loss, a hereditary condition that becomes more common with age and after menopause [3] [4]. The American Academy of Dermatology (AAD) says, "For most women, FPHL begins in midlife, when a woman is in her 40s, 50s, or 60s." It adds that hormones may also play a role, because FPHL is more common after menopause [3].
Two terms help here. Female pattern hair loss (FPHL) is a slow shrinking of hair follicles [12]. Thick terminal hairs are replaced, cycle by cycle, by fine and short vellus hairs [12]. Women do not lose all their hair from it, as some men do [3]. The part widens instead, and hair near the temples can recede [3].
Telogen effluvium is different. It is excess shedding, and it often follows a stressor such as losing 20 pounds or more, surgery or a high fever [13]. The AAD calls shedding of 50 to 100 hairs a day normal [13].
The numbers rise with age. In a survey in Maryborough, Australia, mid-frontal hair loss affected 57% of women aged 80 and over [14]. In a Thai study of 178 healthy postmenopausal women aged 50 to 65, 52.2% had FPHL [15]. Most cases were mild, with 73.2% at Ludwig grade I [15]. Neither sample was American, so treat the exact shares as a range, not a forecast for Charleston.
One factor held up after adjustment in the Thai study. A body mass index of 25 or higher was linked to FPHL, with an adjusted odds ratio of 2.65 [15].
Menopause itself matters. A 2025 systematic review of 40 studies found that alopecia had the strongest postmenopausal link of the common skin conditions it covered [16]. Earlier or surgical menopause carried greater risk [16].
None of these studies can tell you why your own hair is thinning. That takes a history, an exam and often blood work.
Section 02 / Labs first
The labs worth running first, and what each one can rule out
The labs worth running before PRP are the ones that can find a treatable cause. That means thyroid blood tests and iron studies, plus hormone tests when your history points that way. The AAD says you may need a blood test or scalp biopsy when a disease, vitamin deficiency, hormone imbalance or infection could be the cause [5]. PRP treats none of these.
Start with the thyroid. Nearly 5 in 100 Americans age 12 and older have hypothyroidism, and women are much more likely than men to develop it [9]. Most cases are mild [9]. Dry, thinning hair is a listed symptom [9]. The NIDDK says the diagnosis cannot rest on symptoms alone, so doctors use thyroid blood tests [9]. Treatment replaces the missing hormone, usually with a levothyroxine pill [9]. The AAD says treating the thyroid disease can reverse the hair loss [1].
Iron is harder. The AAD says too little iron can cause noticeable hair loss [1]. But the definition of low iron changes the answer. The HEIRS study screened 40,381 women aged 25 to 54 (data collected 2001 to 2003) [10]. By the World Health Organization definition, ferritin below 15 ng/mL, 10.57% had iron deficiency [10]. With a cutoff below 25 ng/mL, the share was 21.23% [10]. Our arithmetic: the count doubles, from the same blood samples.
Menopause status moves ferritin too. In NHANES data, median ferritin was 43 ng/mL in premenopausal women and 98 ng/mL in postmenopausal women [17]. The same research letter says premenopausal women are more likely to have iron deficiency anemia because of heavy menstrual bleeding [17]. If your periods have become heavier, ask about iron.
To be plain: those are research definitions of iron deficiency, not hair targets. No guideline we found sets a ferritin level for hair growth. This guide does not state one.
| What to check | What it can rule out | What the source says | Why it matters before PRP |
|---|---|---|---|
| Thyroid blood tests | Hypothyroidism | Nearly 5 in 100 Americans age 12 and older; thinning hair is a symptom [9] | Hypothyroidism is treated with levothyroxine, usually a pill [9] |
| Iron studies, including ferritin | Iron deficiency | Too little iron can cause hair loss [1]; prevalence doubled between two ferritin definitions in one study [10] | Ask which definition your clinician uses |
| Hemoglobin with ferritin | Iron deficiency anemia | Premenopausal women are more likely to have it, from heavy bleeding [17] | Heavier periods raise the question |
| Hormone tests chosen from your history | Hormone imbalance | The AAD lists hormone imbalance as a reason for a blood test [5] | A hormone cause needs its own treatment |
| A history of recent months | Telogen effluvium | Shedding shows up a few months after a stressor [13] | Shedding often stops on its own [13] |
Ready to find the cause first? Book a hair loss evaluation with Solcara Health.
Section 03 / PRP evidence
What PRP does for women's hair, by the evidence
PRP, or platelet-rich plasma, is made from your own blood: a machine separates it into parts, and the plasma is injected into the scalp [18]. A meta-analysis of seven studies in women found higher terminal hair density, with no significant increase in hair thickness [2]. Using PRP for hair is off-label in the US [19] [20]. A 2015 article on FDA policy found nearly all PRP kits were cleared for bone graft use [19].
The women-only analysis is small, and its authors say so. They wrote that "caution is recommended in the interpretation of these results until they can be replicated in larger and more representative samples" [2].
The larger analyses include men. A 2025 review of 43 randomized trials with 1,877 participants, across alopecia types, found that activated PRP increased hair density compared with placebo [11]. PRP did not significantly affect hair thickness [11]. All three authors work at BTI Biotechnology Institute and declare this as a competing financial interest [11]. BTI sells a plasma rich in growth factors system, PRGF-Endoret [21].
| Analysis | Who was studied | Size | Density | Thickness | Note |
|---|---|---|---|---|---|
| J Dermatolog Treat, 2022 [2] | Women only, androgenetic alopecia | 7 studies | Increased vs control | No significant increase | Authors urge caution |
| Aesthetic Plastic Surgery, 2025 [6] | Men and women, androgenetic alopecia | 9 RCTs, 451 people | No significant difference vs topical minoxidil | Not reported in abstract | Satisfaction higher with PRP |
| Dermatology and Therapy, 2025 [11] | Men and women, all alopecia types | 43 RCTs, 1,877 people | Activated PRP increased vs placebo | No significant effect | Authors work for a PRP system maker [11] [21] |
J Dermatolog Treat, 2022 [2]
Women only, androgenetic alopecia
- Density
- Increased vs control
- Thickness
- No significant increase
Aesthetic Plastic Surgery, 2025 [6]
Men and women, androgenetic alopecia
- Density
- No significant difference vs topical minoxidil
- Thickness
- Not reported in abstract
Dermatology and Therapy, 2025 [11]
Men and women, all alopecia types
- Density
- Activated PRP increased vs placebo
- Thickness
- No significant effect
PRP raised hair density in the women-only analysis; thickness did not change significantly. [2]
Two of the three analyses include men. The authors of the 43-trial analysis work for a PRP system maker. [6][11][21]
Sources: PMID 36264022, 41219547 and 40944844. Date range: 2022 to 2025. [2][6][11]
Read the 2025 comparison with minoxidil closely. Its authors wrote that the analysis "does not demonstrate a clear advantage of PRP over minoxidil in key clinical outcomes such as hair density" [6].
Protocols are not standard. The AAD says, "Most patients return once a month for 3 months and then once every 3 to 6 months" [18]. A review of 19 alopecia studies, 16 in androgenetic alopecia, favored 3 to 4 monthly sessions, but said study differences prevented direct comparison [22]. A 2023 meta-analysis found studies varied in preparation, dose, number of sessions and injection technique [23].
So ask how the clinic prepares its PRP and how many sessions it plans. Session count drives the cost. For prices, see what PRP for hair costs in Charleston.
Section 04 / Minoxidil
Minoxidil, including low-dose oral, compared with PRP
The AAD calls topical minoxidil the most-recommended treatment for female pattern hair loss [3]. A Cochrane review of 47 trials with 5,290 women found that minoxidil roughly doubled the chance of moderate to marked self-rated regrowth compared with placebo, with no difference between 2% and 5% strengths [12]. Oral minoxidil is a prescription blood pressure tablet [7]. Its use for hair is off-label, and the tablet label carries a boxed warning [7].
The Cochrane result in plain numbers: 157 of 593 women on minoxidil reported moderate to marked regrowth, against 77 of 555 on placebo [12]. Our arithmetic: about 26% against about 14%. Seventeen of the 47 trials studied minoxidil [12].
A phase III trial of 404 women tested once-daily 5% foam [24]. At 24 weeks, it regrew 9.1 more hairs per square centimeter than the vehicle foam [24]. Scalp irritation and facial hair growth were uncommon [24]. The women's foam label says results may occur at 3 months, and some women need at least 6 months [25]. It also says, "This product will not work for all women" [25].
Low-dose oral minoxidil deserves a clear look. The tablet label warns that minoxidil "may produce serious adverse effects," including pericardial effusion, fluid around the heart [7]. Its labeled use is limited to hard-to-control high blood pressure [7]. A retrospective study followed 1,404 patients taking low doses for hair, 67.2% of them women [8]. Only 1.7% stopped because of side effects, and unwanted hair growth affected 15.1% [8]. That study had no control group [8].
Combining treatments has thin support. In five randomized trials, adding PRP to topical minoxidil improved hair density [26]. The certainty of evidence was rated low to very low [26].
| Option | FDA status for hair | How it is used | Best evidence | Main caution |
|---|---|---|---|---|
| Topical minoxidil, 2% or 5% | Approved for women, non-prescription [3] | 5% women's foam once daily [25] | 17 of 47 trials in a Cochrane review of women [12] | Scalp irritation [3] |
| Low-dose oral minoxidil | Off-label; tablets are labeled for high blood pressure only [7] | Daily tablet, by prescription [7] | Retrospective, 1,404 patients [8] | Boxed warning [7] |
| PRP | Off-label [19] [20]; a 2015 article found nearly all PRP kits cleared for bone graft use [19] | Monthly injections, then maintenance [18] | Women-only meta-analysis, 7 studies [2] | Protocols vary [23] |
Section 05 / The visit
What a hair loss visit in Charleston should include
A hair loss visit in Charleston should start with questions and an exam, not a treatment plan. The AAD describes the steps. Your clinician asks how long you have had hair loss and how fast it came on [5]. Then the clinician looks at your scalp and nails and gently pulls on your hair [5]. A blood test or scalp biopsy follows when a disease, deficiency, hormone imbalance or infection is suspected [5].

Here is the order to expect, and what to bring.
- A timeline. When did you notice it, and did it come on quickly [5]? Note any stressor in the months before, such as surgery or a large weight loss [13].
- Your period history. Heavier bleeding is a reason to check iron [17].
- An exam of the scalp and nails, and a pull test [5].
- Labs chosen from your history. Expect thyroid blood tests and iron studies, plus hormone tests when your history points to them [5] [9]. Bring any results from the past year.
- A baseline you can compare against. In the Thai study, researchers assessed FPHL with standardized photos and trichoscopy, a magnified scalp exam [15]. Ask how the clinic will record your starting point.
- A treatment talk that covers all three options. Topical minoxidil, oral minoxidil and PRP, with the evidence for each [2] [7] [12].
Timing matters. The AAD says, "Treatment delivers the best results when started at the first sign of hair loss" [3]. Waiting a year to see if it settles has a cost.
Solcara Health offers thyroid care, full-panel labs and PRP hair restoration. If you live outside South Carolina, check your own state's rules and ask your own clinician.
My view: if a clinic offers you PRP before anyone has asked about your periods or checked your thyroid, ask why.
Section 06 / Questions
Perimenopause Hair Thinning Questions Answered
Can perimenopause cause hair loss?
Hair loss becomes more common after menopause [15] [16]. The AAD says female pattern hair loss usually begins in a woman's 40s, 50s or 60s and that hormones may play a role [3]. A 2025 review of 40 studies found alopecia had the strongest postmenopausal link of the common skin conditions it covered [16]. Thyroid disease and too little iron can also cause hair loss, so they are worth ruling out [1].
What blood tests check for hair loss in women?
There is no single hair loss panel. Thyroid blood tests and iron studies are a sensible starting point, because hypothyroidism and iron deficiency are common in women [9] [10]. Hormone tests are added when your history suggests a hormone imbalance [5]. No guideline we found sets a ferritin level for hair. Ask which ferritin definition your clinician is using, because definitions differ [10].
Does PRP work for thinning hair in women?
It increases hair density, with no clear gain in thickness. A meta-analysis of seven studies in women found higher terminal hair density and no significant increase in thickness [2]. A 2025 analysis of men and women found no significant density difference between PRP and topical minoxidil [6]. Using PRP for hair loss is off-label in the US [19] [20].
Is low-dose oral minoxidil safe for women?
It is off-label for hair [7]. The tablet label carries a boxed warning about serious adverse effects, including pericardial effusion [7]. In a retrospective study of 1,404 patients, two-thirds of them women, 1.7% stopped because of side effects [8]. Whether it fits you is a decision to make with a prescriber who knows your heart and blood pressure history.
How many PRP sessions are needed for hair?
There is no standard [23]. The AAD says most patients return once a month for 3 months, then every 3 to 6 months [18]. A systematic review favored 3 to 4 monthly sessions but found the studies too different to compare directly [22]. Ask the clinic how many sessions it plans before you start.
Section 07 / Bottom line
Bottom line: find the cause, then choose the treatment
Hair thinning in perimenopause is common, and the usual cause is female pattern hair loss [3] [4]. But thyroid disease and iron deficiency are common in women too, and both show up on blood work [9] [10].
So check those first. Then weigh the treatments on their evidence. The AAD calls topical minoxidil the most-recommended treatment for female pattern hair loss [3]. In the women-only analysis, PRP added hairs, with no significant gain in thickness [2]. Oral minoxidil is off-label for hair, and the tablet label carries a boxed warning about serious adverse effects [7]. No treatment here comes with a promise, and the foam label says plainly that it will not work for all women [25].
Solcara Health sees patients at 496 Bramson Ct in Mount Pleasant and at The Longevity Club, 163 Rutledge Ave in downtown Charleston. To start with an evaluation, call 843-981-0870 or book online.
References
- [1] American Academy of Dermatology. Hair loss: who gets and causes. Undated page, accessed November 9, 2026. https://www.aad.org/public/diseases/hair-loss/causes/18-causes
- [2] de Oliveira AFQ et al. Use of autologous platelet-rich plasma in androgenetic alopecia in women: a systematic review and meta-analysis. Journal of Dermatological Treatment. October 2022 (online). https://pubmed.ncbi.nlm.nih.gov/36264022/
- [3] American Academy of Dermatology. Female pattern hair loss: overview. Last updated December 13, 2022. https://www.aad.org/public/diseases/hair-loss/types/female-pattern
- [4] Kanti V et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men, short version. Journal of the European Academy of Dermatology and Venereology (European Dermatology Forum). November 2017. https://pubmed.ncbi.nlm.nih.gov/29178529/
- [5] American Academy of Dermatology. Hair loss: diagnosis and treatment. Last updated December 13, 2022. https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat
- [6] Umar M et al. Comparative efficacy and safety of platelet rich plasma (PRP) versus topical minoxidil for androgenetic alopecia: a systematic review and meta-analysis. Aesthetic Plastic Surgery. November 2025. https://pubmed.ncbi.nlm.nih.gov/41219547/
- [7] DailyMed (U.S. National Library of Medicine). Minoxidil tablet prescribing information (NuCare Pharmaceuticals). Updated September 18, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5bc9f21d-c959-89ee-e063-6294a90a0a62
- [8] Vano-Galvan S et al. Safety of low-dose oral minoxidil for hair loss: a multicenter study of 1404 patients. Journal of the American Academy of Dermatology. February 2021. https://pubmed.ncbi.nlm.nih.gov/33639244/
- [9] National Institute of Diabetes and Digestive and Kidney Diseases (NIH). Hypothyroidism (underactive thyroid). Last reviewed March 2021. https://www.niddk.nih.gov/health-information/endocrine-diseases/hypothyroidism
- [10] Barton JC et al. Prevalence of iron deficiency using 3 definitions among women in the US and Canada. JAMA Network Open. June 2024. https://pubmed.ncbi.nlm.nih.gov/38848068/
- [11] Anitua E, Tierno R, Alkhraisat MH. Platelet-rich plasma in the management of alopecia: a systematic review and meta-analysis. Dermatology and Therapy. September 2025. https://pubmed.ncbi.nlm.nih.gov/40944844/ (full text and competing-interest declaration: https://pmc.ncbi.nlm.nih.gov/articles/PMC12550094/)
- [12] van Zuuren EJ et al. Interventions for female pattern hair loss. Cochrane Database of Systematic Reviews. May 2016. https://pubmed.ncbi.nlm.nih.gov/27225981/
- [13] American Academy of Dermatology. Hair shedding. Undated page, accessed November 9, 2026. https://www.aad.org/public/diseases/hair-loss/insider/shedding
- [14] Gan DCC, Sinclair RD. Prevalence of male and female pattern hair loss in Maryborough. Journal of Investigative Dermatology Symposium Proceedings. December 2005. https://pubmed.ncbi.nlm.nih.gov/16382660/
- [15] Chaikittisilpa S et al. Prevalence of female pattern hair loss in postmenopausal women: a cross-sectional study. Menopause. February 2022. https://pubmed.ncbi.nlm.nih.gov/35357365/
- [16] Roster K et al. Menopause and common dermatoses: a systematic review. American Journal of Clinical Dermatology. December 2025. https://pubmed.ncbi.nlm.nih.gov/41331233/
- [17] Al Ta'ani O et al. Diagnostic serum ferritin thresholds and prevalence of iron deficiency anemia (research letter). JAMA Internal Medicine. August 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC12379125/
- [18] American Academy of Dermatology. Hair loss: diagnosis and treatment (platelet-rich plasma). Last updated December 13, 2022. https://www.aad.org/public/diseases/hair-loss/treatment/diagnosis-treat
- [19] Beitzel K et al. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine. Journal of Knee Surgery. February 2015. https://pubmed.ncbi.nlm.nih.gov/25268794/
- [20] Lama SBC et al. Physical treatments and therapies for androgenetic alopecia. Journal of Clinical Medicine. August 2024. https://pubmed.ncbi.nlm.nih.gov/39124800/
- [21] BTI Biotechnology Institute. Company website: Regenerative Medicine, PRGF-Endoret. Accessed November 9, 2026. https://bti-biotechnologyinstitute.com/en/
- [22] Hesseler MJ, Shyam N. Platelet-rich plasma and its utilities in alopecia: a systematic review. Dermatologic Surgery. January 2020. https://pubmed.ncbi.nlm.nih.gov/31211715/
- [23] Olisova O et al. Meta-analysis on the efficacy of platelet-rich plasma in patients with androgenetic alopecia. International Journal of Trichology. July 2023. https://pubmed.ncbi.nlm.nih.gov/38765721/
- [24] Bergfeld W et al. A phase III, multicenter, parallel-design clinical trial to compare the efficacy and safety of 5% minoxidil foam versus vehicle in women with female pattern hair loss. Journal of Drugs in Dermatology. July 2016. https://pubmed.ncbi.nlm.nih.gov/27391639/
- [25] DailyMed (U.S. National Library of Medicine). Minoxidil (for women) aerosol foam 5%, Drug Facts label (CVS Pharmacy). Updated October 29, 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b10eb8fd-8301-4c38-af4c-220fe5c3b592
- [26] Yao J et al. The additive value of platelet-rich plasma to topical minoxidil in the treatment of androgenetic alopecia: a systematic review and meta-analysis. PLOS ONE. August 2024. https://pubmed.ncbi.nlm.nih.gov/39197003/

The information in this article is for educational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making any medical decisions. Oral minoxidil is not FDA approved for hair loss, and using PRP for hair loss is off-label. This article makes no promise of results. Solcara Health, 496 Bramson Ct, Ste 120, Mount Pleasant, SC 29464 and 163 Rutledge Ave, Ste 202, Charleston, SC 29403. 843-981-0870.

Quick Links
